Mesotherapy: ingredients, evidence and injection safety
Mesotherapy describes multiple small injections of selected substances rather than one standardized product.
Consultation information
On this page
What exactly is proposed?
Ask for the exact preparation and intended change before agreeing to a plan. Skin appearance is not one diagnosis, and mixtures can differ substantially. A study using one formulation or outcome cannot be treated as evidence for a different product. M1M2
| Example | What differs | Evidence context | Main limit | Question to ask |
|---|---|---|---|---|
| Vitamin and HA mixture | A particular ingredient combination | A small older study found no significant clinical improvement | Not a verdict on every formulation | Does this mixture have matching data? M1 |
| Studied HA composite | Defined formulation and protocol | A newer trial reported selected improvements | Does not cover all marketed mixtures | Does the proposed product match? M2 |
| Unidentified preparation | Contents or provenance unclear | Cannot be assessed from the name alone | Injection safety cannot be assumed | Can identity and traceability be established? M3 |
Differences between studies do not justify either a universal promise or a blanket claim that every preparation is ineffective. Consider the actual ingredients, comparison group, measured outcome and follow-up; a favorable study does not remove uncertainty about uncommon harms. M1M2
Options and evidence limits
If an injection is proposed, compare its expected benefit with suitable alternatives or postponement. The clinician should explain the preparation, route and follow-up, including how a problem would be assessed. Do not accept an unidentified mixture on the strength of a general treatment name. M2M3
A 2026 trial studied a particular sodium-hyaluronate composite against no intervention and reported improvements. It was not a comparison of every product or a guarantee of permanent change. Funding and study design are relevant when interpreting the findings. M1M2
Before an injection plan
Discuss allergies, medicines, bleeding problems, previous injections and active skin inflammation or infection. Product-specific precautions matter, especially if a filler-like material is proposed. Do not change prescribed medicines yourself; assess suitability before committing to repeated sessions. F1
Possible adverse effects
Pain, bruising, swelling, infection or inflammatory reactions may occur after injections. Historical investigations describe prolonged skin reactions after unsafe mesotherapy. If the material acts as a filler, nodules and vascular injury require additional discussion; the risk is not identical for every mixture. M3F1
Aftercare and review
Ask for product-specific aftercare and a clear contact route. Persistent lumps or worsening reactions need assessment rather than another session. Review the original concern, any measurable change and adverse effects before deciding whether repeating treatment remains reasonable. M2M3
Questions about mesotherapy
Does every mixture work the same way?
No. Mesotherapy is a broad delivery term. Different ingredients and preparation methods require their own evidence and risk assessment; a result for one mixture should not be borrowed for another. M1M2
Do newer trials prove every product works?
No. Newer findings can support the particular preparation and outcomes studied. They do not validate an unspecified cocktail, other anatomical areas, unlimited combinations or permanent results. Matching the proposed product to the study matters. M2
Are small injections free of infection risk?
No. Small punctures still breach the skin. Sterile technique and appropriate, traceable substances are necessary. A historical outbreak illustrates possible harm from unsafe practice, but cannot quantify the risk of your particular proposed treatment. M3
Does vitamin content mean it is harmless?
No. A familiar ingredient taken by mouth or applied to intact skin is not automatically appropriate for injection. The complete preparation, route, allergies and any additional substances must be evaluated individually. F1
How should repeat sessions be decided?
Repetition should follow an agreed review of benefit, tolerability and the reason for treatment. There is no universal package for all mixtures and concerns. Lack of benefit or a suspected complication should prompt reassessment, not automatic continuation. M2